Meta Biomed Co (XKRX:059210) Total Liabilities : ₩85,445 Mil (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Meta Biomed Co Total Liabilities?

Meta Biomed Co's Total Liabilities for the quarter that ended in Mar. 2024 was ₩85,445 Mil.

Meta Biomed Co's quarterly Total Liabilities declined from Sep. 2023 (₩58,476.82 Mil) to Dec. 2023 (₩57,462.38 Mil) but then increased from Dec. 2023 (₩57,462.38 Mil) to Mar. 2024 (₩85,444.62 Mil).

Meta Biomed Co's annual Total Liabilities increased from Dec. 2021 (₩43,029.52 Mil) to Dec. 2022 (₩57,633.12 Mil) but then declined from Dec. 2022 (₩57,633.12 Mil) to Dec. 2023 (₩57,462.38 Mil).

Meta Biomed Co Total Liabilities Historical Data

The historical data trend for Meta Biomed Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meta Biomed Co Total Liabilities Chart

Meta Biomed Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

48,429.63

58,330.51

43,029.52

57,633.12

57,462.38

Meta Biomed Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															57,597.21	59,412.24	58,476.82	57,462.38	85,444.62

Meta Biomed Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Meta Biomed Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	44471.257	+	(12502.091	+	226.479
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	262.549)
	=	57,462

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	130124.258	-	72661.882
	=	57,462

Meta Biomed Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	54756.128	+	(30081.443	+	292.12100000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	314.931)
	=	85,445

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	163775.118	-	78330.495
	=	85,445

Meta Biomed Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Meta Biomed Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Meta Biomed Co (XKRX:059210) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Meta Biomed Co Ltd (XKRX:059210) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

634 Yeonje-ri, Gangoe-myeon, Cheongwon-gun, Chungbuk, KOR, 363-951

Website

http://www.meta-biomed.com

Meta Biomed Co Ltd manufactures and markets suture and dental supplies. The company's dental products include endodontic materials, restorative materials, and bone graft material, as well as equipment, including Endo motor, and Endo System. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics and incontinence meshs; bone products consisting of bone substitutes and cement; and medical products, including endoscope and ultrasonic products.

Meta Biomed Co (XKRX:059210) Headlines

No Headlines